• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?心力衰竭情况下广泛的心房纤维化是否与房颤负荷降低有关?
Pacing Clin Electrophysiol. 2018 Oct;41(10):1289-1297. doi: 10.1111/pace.13474. Epub 2018 Sep 9.
2
Associations between cardiac fibrosis and permanent atrial fibrillation in advanced heart failure.心脏纤维化与晚期心力衰竭中永久性心房颤动的相关性。
Physiol Res. 2013;62(3):247-55. doi: 10.33549/physiolres.932409. Epub 2013 Mar 14.
3
Functional characterization of atrial electrograms in a pacing-induced heart failure model of atrial fibrillation: importance of regional atrial connexin40 remodeling.在起搏诱导的心房颤动心力衰竭模型中心房电图的功能特征:区域性心房连接蛋白 40 重构的重要性。
J Cardiovasc Electrophysiol. 2013 May;24(5):573-82. doi: 10.1111/jce.12089. Epub 2013 Feb 19.
4
HDAC2-dependent remodeling of K2.2 (KCNN2) and K2.3 (KCNN3) K channels in atrial fibrillation with concomitant heart failure.在伴有心力衰竭的心房颤动中,HDAC2 依赖性重塑 K2.2(KCNN2)和 K2.3(KCNN3)K 通道。
Life Sci. 2021 Feb 1;266:118892. doi: 10.1016/j.lfs.2020.118892. Epub 2020 Dec 10.
5
DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.DL-3-正丁基苯酞通过抑制心力衰竭大鼠心房结构重塑降低心房颤动易感性。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Mar;391(3):323-334. doi: 10.1007/s00210-017-1457-1. Epub 2017 Dec 30.
6
Does Left Ventricular Systolic Function Matter? Treating Atrial Fibrillation in HFrEF Versus HFpEF.左心室收缩功能重要吗?射血分数降低的心力衰竭与射血分数保留的心力衰竭患者的心房颤动治疗
Cardiol Clin. 2019 May;37(2):157-166. doi: 10.1016/j.ccl.2019.01.008.
7
A temporal window of vulnerability for development of atrial fibrillation with advancing heart failure.随着心力衰竭的进展,心房颤动的易损期窗口。
Eur J Heart Fail. 2014 Mar;16(3):271-80. doi: 10.1002/ejhf.28. Epub 2014 Jan 9.
8
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K) channels in murine disease models: focus on TASK-1.心房颤动和心力衰竭相关的双孔钾 (K) 通道在小鼠疾病模型中的重构:聚焦 TASK-1。
Basic Res Cardiol. 2018 Jun 7;113(4):27. doi: 10.1007/s00395-018-0687-9.
9
Effects of renal sympathetic denervation on the atrial electrophysiology in dogs with pacing-induced heart failure.肾交感神经去神经支配对起搏诱导性心力衰竭犬心房电生理的影响。
Pacing Clin Electrophysiol. 2014 Oct;37(10):1357-66. doi: 10.1111/pace.12429. Epub 2014 May 30.
10
Atrial fibrosis and the mechanisms of atrial fibrillation.心房纤维化与心房颤动的机制
Heart Rhythm. 2007 Mar;4(3 Suppl):S24-7. doi: 10.1016/j.hrthm.2006.12.040. Epub 2006 Dec 28.

引用本文的文献

1
"Pharmacological" analysis of atrial fibrillation maintenance mechanism: reentry, wavelets, or focal?心房颤动维持机制的“药理学”分析:折返、小波还是局灶性?
Front Cardiovasc Med. 2025 Jan 24;12:1447542. doi: 10.3389/fcvm.2025.1447542. eCollection 2025.
2
Characterization of patients with extensive left atrial myopathy referred for atrial fibrillation ablation: incidence, predictors, and outcomes.因心房颤动消融术就诊的广泛性左心房肌病患者的特征:发病率、预测因素及预后
Clin Res Cardiol. 2025 Jan;114(1):126-137. doi: 10.1007/s00392-024-02467-6. Epub 2024 Jun 26.
3
Advances in basic and translational research in atrial fibrillation.心房颤动的基础和转化研究进展。
Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220174. doi: 10.1098/rstb.2022.0174. Epub 2023 May 1.
4
Research Progress of Myocardial Fibrosis and Atrial Fibrillation.心肌纤维化与心房颤动的研究进展
Front Cardiovasc Med. 2022 Jul 25;9:889706. doi: 10.3389/fcvm.2022.889706. eCollection 2022.
5
Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms.抗癌药物引起的心房颤动及其潜在机制。
J Cardiovasc Pharmacol. 2022 Oct 1;80(4):540-546. doi: 10.1097/FJC.0000000000001182.
6
Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?2020 年抗心律失常药物终止心律失常的抗房颤药理学和机制研究进展:我们处于哪个阶段?
J Cardiovasc Pharmacol. 2020 Nov;76(5):492-505. doi: 10.1097/FJC.0000000000000892.
7
Cardiac fibrosis.心肌纤维化。
Cardiovasc Res. 2021 May 25;117(6):1450-1488. doi: 10.1093/cvr/cvaa324.

本文引用的文献

1
Fibrosis and Atrial Fibrillation: Computerized and Optical Mapping; A View into the Human Atria at Submillimeter Resolution.纤维化与心房颤动:计算机与光学标测;以亚毫米分辨率观察人类心房。
JACC Clin Electrophysiol. 2017 Jun;3(6):531-546. doi: 10.1016/j.jacep.2017.05.002. Epub 2017 Jun 20.
2
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.欧洲心律协会/美国心律学会/亚太心律学会/拉丁美洲心律学会关于心房心肌病的专家共识:定义、特征及临床意义
Heart Rhythm. 2017 Jan;14(1):e3-e40. doi: 10.1016/j.hrthm.2016.05.028. Epub 2016 Jun 10.
3
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure.超声心动图衍生的脉搏波速度与舒张功能障碍与收缩性心力衰竭患者心房颤动发生率增加相关。
Echocardiography. 2016 Jul;33(7):1024-31. doi: 10.1111/echo.13230. Epub 2016 Jun 9.
4
Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction.导致心力衰竭住院的临床因素、心力衰竭特征及结局分析:射血分数降低、边界值和保留的心衰患者。
JACC Heart Fail. 2016 Jun;4(6):464-72. doi: 10.1016/j.jchf.2016.02.017.
5
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial.心力衰竭患者新发心房颤动相关的临床和超声心动图因素——WARCEF试验的亚组分析
Circ J. 2016;80(3):619-26. doi: 10.1253/circj.CJ-15-1054. Epub 2016 Jan 22.
6
Prognostic Impact of New-Onset Atrial Fibrillation in Patients With Chronic Heart Failure - A Report From the CHART-2 Study.慢性心力衰竭患者新发心房颤动的预后影响——CHART-2研究报告
Circ J. 2016;80(1):157-67. doi: 10.1253/circj.CJ-15-0783. Epub 2015 Dec 7.
7
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.稳定性冠心病患者应用伊伐布雷定治疗后的心动过缓和心房颤动:来自 SIGNIFY 研究的分析。
Eur Heart J. 2015 Dec 7;36(46):3291-6. doi: 10.1093/eurheartj/ehv451. Epub 2015 Sep 17.
8
Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.急性心力衰竭与心房颤动:来自奈西立肽治疗失代偿性心力衰竭临床有效性急性研究(ASCEND-HF)试验的见解
J Am Heart Assoc. 2015 Aug 24;4(8):e002092. doi: 10.1161/JAHA.115.002092.
9
Atrial remodeling, fibrosis, and atrial fibrillation.心房重塑、纤维化与心房颤动。
Trends Cardiovasc Med. 2015 Aug;25(6):475-84. doi: 10.1016/j.tcm.2014.12.015. Epub 2014 Dec 31.
10
Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.射血分数保留或降低的晚期心力衰竭患者的左心房重构与功能
Circ Heart Fail. 2015 Mar;8(2):295-303. doi: 10.1161/CIRCHEARTFAILURE.114.001667. Epub 2015 Jan 15.

心力衰竭情况下广泛的心房纤维化是否与房颤负荷降低有关?

Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

作者信息

Burashnikov Alexander, Antzelevitch Charles

机构信息

Lankenau Institute for Medical Research, Wynnewood, PA, USA.

Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

Pacing Clin Electrophysiol. 2018 Oct;41(10):1289-1297. doi: 10.1111/pace.13474. Epub 2018 Sep 9.

DOI:10.1111/pace.13474
PMID:30152017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6167143/
Abstract

Atrial fibrillation (AF) affects 10-50% of patients with chronic heart failure (HF) and is associated with poor long-term prognosis. AF is commonly associated with atrial structural remodeling (ASR), principally characterized by atrial dilatation and fibrosis. However, the occurrence of AF in the full spectrum of ASR encountered in patients with HF is poorly defined. Experimental studies have presented evidence that extensive ASR can be accompanied with a reduced burden of AF, secondary to a prominent depression of atrial excitability. This reduction in AF burden is associated with severe atrial fibrosis rather than with dilatation. Clinical studies of patients with HF point to the possibility that advanced ASR is associated with a less frequent AF occurrence than moderate ASR. Our goal in this review is to introduce the hypothesis that AF is less likely to occur in severe versus moderate atrial ASR in the setting of HF and that it is severe atrial fibrosis-associated depression of atrial excitability that reduces AF burden.

摘要

心房颤动(AF)影响10%-50%的慢性心力衰竭(HF)患者,并与不良的长期预后相关。AF通常与心房结构重塑(ASR)有关,主要特征是心房扩张和纤维化。然而,在HF患者中遇到的整个ASR范围内AF的发生情况尚不清楚。实验研究表明,广泛的ASR可伴有AF负担减轻,这是由于心房兴奋性显著降低所致。AF负担的这种减轻与严重心房纤维化有关,而非与扩张有关。HF患者的临床研究表明,与中度ASR相比,晚期ASR与AF发生频率较低的可能性相关。本综述的目的是提出这样一种假设:在HF背景下,严重心房ASR与中度心房ASR相比,AF发生的可能性较小,并且是严重心房纤维化相关的心房兴奋性降低减轻了AF负担。